USPTO serial 79314785
HYTEST
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 4, 2022
- Examiner
- SEGAL, MOLLY DANIELA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HYTEST?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Elizabeth A. Cominolli
Elizabeth A. Cominolli Markert & Cominolli PLLC75 S. Clinton Ave., Suite 510Rochester, NY 14604UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; Biological preparations for use in cell cultures, other than for medical or veterinary purposes; Diagnostic preparations, other than for medical or veterinary purposes; Biochemicals, namely monoclonal antibodies for scientific purposes, other than for medical or veterinary use; Tagged antibodies for scientific use; Tagged antibodies for laboratory use; Monoclonal antibodies for diagnostic use, other than for medical use; Monoclonal antibodies for scientific use; Monoclonal antibodies for industrial use; Monoclonal antibody reagents, other than for medical use; Reagents for scientific purposes; Laboratory reagents for scientific use; Reagents for use in the development of monoclonal antibodies, other than for medical or veterinary purposes | ACTIVE | — |
| 005 | Diagnostic preparations for medical purposes; In vitro diagnostic preparations for medical use; Diagnostic preparations for veterinary purposes; Reagents for medical use; Veterinary diagnostic reagents; Diagnostic preparations, namely, antigens for medical use; Antibodies for medical use; Monoclonal antibodies for medical use; Medical preparations, namely, polyclonal antibodies; Blood plasma; serums for use in medical laboratory research in the field of biotechnology and for manufacturing medical preparations; Monoclonal antibodies and antigens used to carry out medical laboratory tests; Antibodies, antigens, serums and blood plasma for immunoassay reagent development on various platforms for medical use; Monoclonal antibodies and antigens that enable the development of quantitative immunoassays for the detection of various biomarkers for medical use; Antibodies and antigens that enable the development of immunoassays for the detection of infectious diseases causing pathogens; Antibodies and antigens that allow the development of quantitative immunoassays for detecting inflammatory markers for medical use | ACTIVE | — |
| 035 | Retail store services featuring medical preparations; Retail store services featuring veterinary preparations; Retail store services featuring antibodies, antigens, blood plasma and serums; Online retail store services featuring medical preparations; Online retail store services featuring veterinary preparations; Online retail store services featuring antibodies, antigens, blood plasma and serums; Wholesale store services featuring medical preparations; Wholesale store services featuring veterinary preparations; Wholesale store services featuring antibodies, antigens, blood plasma and serums; Online wholesale store services featuring antibodies, antigens, blood plasma and serums | ACTIVE | — |
| 042 | Research laboratories in the field of biotechnology; Biological research laboratory services; Medical research services; Research and development relating to in vitro diagnostic preparations; Research and development services in the field of antibodies; Research and development services in the field of antigens; Medical laboratory services; Medical laboratory services relating to the production of monoclonal antibodies; Medical laboratory services relating to the production of antigens; Medical laboratory services relating to the production of blood plasma and serums; Testing and authentication for quality control purposes; Biotechnology testing, namely biotechnology research; Testing of pharmaceuticals; Consultancy relating to laboratory testing; Providing scientific information relating to diagnostic in vitro products and their features | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Hytest Oy
- Other trademarks owned by Hytest Oy
- Other trademarks owned by Hytest Oy
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named HYTEST
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 26, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 20, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 26, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 26, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 4, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 4, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 4, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 19, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 19, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 18, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 29, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 29, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 29, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 14, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 14, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 14, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 14, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 14, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 24, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 9, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 13, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 26, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 3, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 3, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 3, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 2, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 26, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 13, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 1, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |